e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Novel clinical features of acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community-acquired pneumonia in pediatric patients with connective tissue disorders: Manifestations and clinical course
Z. Nesterenko, O. Ivanina (Lugansk, Ukraine)
Source:
Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Session:
Novel clinical features of acute and chronic lung diseases
Session type:
Oral Presentation
Number:
2988
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Nesterenko, O. Ivanina (Lugansk, Ukraine). Community-acquired pneumonia in pediatric patients with connective tissue disorders: Manifestations and clinical course. Eur Respir J 2011; 38: Suppl. 55, 2988
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Connective tissue disorders as the factor that changes clinical course of community-acquired pneumonia in children
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011
Community-acquired pneumonia in pediatric patients with heritable connective tissue disorders: Novel phenotypic variants
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Etiology and clinical outcome of community-acquired pneumonias in hospitalized children
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007
Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Prognostic criteria of slowly resolving community-acquired pneumonia in patients with connective tissue dysplasia
Source: Eur Respir J 2004; 24: Suppl. 48, 52s
Year: 2004
Community-acquired pneumonia in outpatients: Microbial etiology
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Community-acquired pneumonia in outpatients: aetiology and outcomes},
Source: Eur Respir J 2012; 40: 931-938
Year: 2012
The prevalence of cardiac diseases in patients with community-acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Predictors of clinical failure in community-acquired pneumonia
Source: Annual Congress 2011 - PG9 Risk stratification and treatment of lower respiratory tract infections
Year: 2011
Etiology of community-acquired pneumonia: an autopsy study
Source: Annual Congress 2006 - Miscellaneous respiratory infections I
Year: 2006
Community-acquired pneumonia: aetiology and severity scores
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Severe community-acquired pneumonia in China: epidemiology and clinical practice
Source: International Congress 2019 – Chinese programme 2019: Part II
Year: 2019
Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a prospective study
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Healthcare-associated pneumonia (HCAP): Clinical features and biomarkers
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Community-acquired pneumonia associated with COPD : a special entity ?
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Hospitalized community-acquired pneumonia in the elderly: etiology and comorbidities
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)?
Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept